Medical Condition News

RSS

Eisai receives FDA approval for BANZEL Oral Suspension to treat seizures linked with LGS

Eisai Inc. today announced that the U.S. Food and Drug Administration has approved BANZEL Oral Suspension, 40 mg/mL, for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in children 4 years and older and adults.

3 Mar 2011

Scientists uncover genetic pathway that affects breast cancer development

Using recent advances in genomics, researchers have uncovered a genetic pathway that affects the development of breast cancer, work that could help predict which patients are at risk of relapse for the disease.

3 Mar 2011

Racial and ethnic groups less likely to receive kidney transplants than others

Not all racial and ethnic groups have equal access to kidney transplantation, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology. The results indicate that the reasons for these disparities are varied and that more focused efforts are needed to address them.

3 Mar 2011

Neurodegenerative Disease Management – meeting the challenge of neurodegenerative diseases

Future Medicine Ltd has today announced the launch of Neurodegenerative Disease Management – a new bimonthly title addressing all the latest trends in the field, from R&D through to clinical application and management, presenting research, findings, analysis and commentaries from experts around the world.

3 Mar 2011

Ventus Medical's Provent Sleep Apnea Therapy granted CE Mark

Ventus Medical, Inc. a privately-held medical device company dedicated to providing novel products to treat sleep-disordered breathing, today announced that it has received CE Mark for its Provent® Sleep Apnea Therapy.

3 Mar 2011

Glenmark Generics granted final FDA approval for generic Xyzal ANDA

Glenmark Generics Inc., USA (GGI), the United States subsidiary of Glenmark Generics Limited (GGL), announced they have been granted final approval for their Abbreviated New Drug Application (ANDA) from the United States Food and Drug Administration (U.S. FDA) for Levocetirizine Dihydrochloride 5 mg tablets, the generic version of UCB Inc.'s Xyzal(R) tablets.

3 Mar 2011

Protalex initiates enrollment in 3rd cohort of PRTX-100 Phase 1b dose escalation clinical study in RA

Protalex, Inc, a clinical stage biopharmaceutical company which is engaged in developing a class of drugs for treating autoimmune and inflammatory diseases, today announced enrollment of the first patients in the 3rd cohort of its ongoing multicenter Phase 1b dose escalation clinical study of PRTX-100 in adult patients with active Rheumatoid Arthritis (RA) being conducted in South Africa. The dose was increased by a factor of two from the 2nd cohort.

3 Mar 2011

Infinity commences IPI-926 Phase 2 clinical trial in rare, life-threatening bone cancer

Infinity Pharmaceuticals, Inc. today announced the initiation of a randomized, double-blind Phase 2 clinical trial to evaluate the safety and efficacy of IPI-926 compared to placebo in patients with metastatic or locally advanced, inoperable chondrosarcoma. The trial is expected to enroll over 100 patients worldwide.

3 Mar 2011

EC grants marketing authorization for InterMune's Esbriet to treat IPF

InterMune, Inc. today announced that the European Commission has granted marketing authorization for Esbriet. Esbriet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis, a progressive and fatal lung disease.

3 Mar 2011

Sarsia grants BerGenBio NOK7 million to continue CellSelect advanced technology platform

BerGenBio has secured NOK7 million from local Sarsia Seed and Development funds to continue its leading research and development activities into new and original cancer treatments.

3 Mar 2011

ContextVision launches MAMMO PlusViewCAD breast cancer detection tool at ECR

ContextVision is pleased to a announce that today at the ECR in Vienna, it is officially launching the first product stemming from its recently announced strategic alliance with NeuSoft Medical Technologies.

3 Mar 2011

ContextVision launches GOPView iRVUltra product at 2011 ECR annual meeting

ContextVision is pleased to announce the showcasing and market launch of a second new product at the 2011 European Congress of Radiology in Vienna.

3 Mar 2011

New insight: p53 protein controls molecular crossroads in glucose metabolic pathway

The gene for the protein p53 is the most frequently mutated in human cancer. It encodes a tumor suppressor, and traditionally researchers have assumed that it acts primarily as a regulator of how genes are made into proteins.

3 Mar 2011

New discovery in glioma-associated metabolic changes

Metabolon, Inc., the leader in metabolomics, biomarker discovery and analysis, announces the publication of "Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome", in The Proceedings of the National Academy of Sciences.

3 Mar 2011

Novel study deepens understanding of how chromosome replication works

A novel study from the Swedish medical university Karolinska Institutet has deepened the understanding of how chromosome replication, one of life's most fundamental processes, works.

3 Mar 2011

New research provides insight into link between sunlight, vitamin D3, MS risk and severity

New research into the neurodegenerative disease, Multiple Sclerosis offers new insight into the link between sunlight, vitamin D3, and MS risk and severity.

3 Mar 2011

Medtronic to make nearly $4 million in 2011 to address non-communicable diseases

In its continued commitment to reduce the global burden of non-communicable diseases, Medtronic, Inc. today announced it will make nearly $4 million in Medtronic Foundation grants in 2011 to international organizations specifically to address diseases such as diabetes and heart disease in developing countries.

3 Mar 2011

Affymetrix releases complete genotyping data set on its website

Affymetrix, Inc. today announced the release of a complete data set of 5 million variants on its website.

3 Mar 2011

Scientists develop simple home-based blood pressure measuring device for diabetics

Many people get stressed when they visit the doctor, leading to blood pressure readings higher than normal. It's called "White Coat Syndrome." And since two-thirds of diabetics suffer from high blood pressure, getting accurate readings is crucial to getting proper care for them.

3 Mar 2011

Joslin launches initiative for primary care physicians to improve diabetes care

Joslin Diabetes Center has launched a groundbreaking initiative for primary care physicians to improve diabetes care.

3 Mar 2011

Medical Condition News

Eisai receives FDA approval for BANZEL Oral Suspension to treat seizures linked with LGS

Scientists uncover genetic pathway that affects breast cancer development

Racial and ethnic groups less likely to receive kidney transplants than others

Neurodegenerative Disease Management – meeting the challenge of neurodegenerative diseases

Ventus Medical's Provent Sleep Apnea Therapy granted CE Mark

Glenmark Generics granted final FDA approval for generic Xyzal ANDA

Protalex initiates enrollment in 3rd cohort of PRTX-100 Phase 1b dose escalation clinical study in RA

Infinity commences IPI-926 Phase 2 clinical trial in rare, life-threatening bone cancer

EC grants marketing authorization for InterMune's Esbriet to treat IPF

Sarsia grants BerGenBio NOK7 million to continue CellSelect advanced technology platform

ContextVision launches MAMMO PlusViewCAD breast cancer detection tool at ECR

ContextVision launches GOPView iRVUltra product at 2011 ECR annual meeting

New insight: p53 protein controls molecular crossroads in glucose metabolic pathway

New discovery in glioma-associated metabolic changes

Novel study deepens understanding of how chromosome replication works

New research provides insight into link between sunlight, vitamin D3, MS risk and severity

Medtronic to make nearly $4 million in 2011 to address non-communicable diseases

Affymetrix releases complete genotyping data set on its website

Scientists develop simple home-based blood pressure measuring device for diabetics

Joslin launches initiative for primary care physicians to improve diabetes care

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News